Prognosis
Filtrar los productos
Marcas
Ver todas las marcas
Tecnologías
Ver todas las tecnologías
Prognosis
Marcas
Ver todas las marcas
Tecnologías
Ver todas las tecnologías
Productos de Prognosis
rBGA (recombinant blood group antigens) for serology
Pretreatment of the patient's serum for detection of antibodies against blood group antigens
Inno-train
Myriad Genetics
Antibody Neutralizing Agents
Real Time PCR (qPCR)
Serology
myChoice CDx
The most comprehensive tumor test to determine Homologous Recombination Deficiency (HDR) Status by studying the BRCA genes in patients with ovarian cancer.
Myriad Genetics
Prognosis
Next Generation Sequencing (NGS)
EndoPredict®
Prognostic and predictive molecular in vitro test to determine the risk of recurrence and the absolute benefit of chemotherapy over the next 15 and 10 years, respectively, in patients with ER+/HER2- primary breast cancer.
Myriad Genetics
Prognosis
Real Time PCR (qPCR)